{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006260",
      "entity_text" : "DNA replication",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:3657",
      "entity_text" : "Hydroxyurea",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Hydroxyurea (HU), an antineoplastic drug used for treatment of HIV, cancer, and myeloproliferative diseases slows the progression of DNA replication machinery by reducing the cell 's deoxyribonucleotide (dNTP) pool.",
  "reading_complete" : "2020-08-08T14:19:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:18:16Z",
  "trigger" : "slows",
  "evidence" : [ "Hydroxyurea (HU), an antineoplastic drug used for treatment of HIV, cancer, and myeloproliferative diseases               slows the progression of DNA replication" ],
  "pmc_id" : "3390589",
  "score" : 0
}